ArticlePloS one2019
MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells.
Karolin Ebert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticlePloS one2019
Karolin Ebert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.